Pyrogen Testing Market Size To Reach $2.49 Billion By 2030

Pyrogen Testing Market Growth & Trends

The global pyrogen testing market size is anticipated to reach USD 2.49 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 11.2% from 2025 to 2030. Increasing demand for therapeutic drugs including pharmaceuticals, biopharmaceuticals, and biologics is the major factor that propels the growth of the market during the forecast period. Pyrogen is a toxic molecular substance that causes fever if induced in an animal or human body. Pyrogen testing is used by pharmaceutical, biopharmaceuticals, biotechnology, and medical devices companies to confirm the absence of pyrogen. Thus, the companies use various methods such as LAL, in vitro pyrogen, and rabbit test to ensure the quality of products.

Increasing prevalence of chronic diseases is another foremost factor supporting market growth. The prevalence of chronic diseases is very high in developed countries and is growing at a high pace in developing countries including China and India. Different factors such as unhealthy diet, smoking, alcohol consumption, and lack of exercise lead to the occurrence of chronic diseases such as cancer, cardiovascular diseases, diabetes, and chronic respiratory diseases.  Hence, there is a growing demand for therapeutic drugs and medical devices for the treatment of such diseases, which in turn is projected to fuel the demand for pyrogen testing to ensure the quality of products including drugs and devices.

 Request a free sample copy or view report summary: Pyrogen Testing Market Report

Pyrogen Testing Market Report Highlights

• Consumables was the largest revenue grossing segment of this market in 2024, owing to the large application of pyrogen testing kits and reagents along with its repetitive purchase.

• Instruments segment accounted for the remarkable share in the market in 2024 and is also expected to showcase significant growth during the forecast period, owing to rising demand for pharmaceutical, biologics, and medical devices for treatment and diagnosis.

• The pharmaceutical and biotechnology companies segment dominated the pyrogen testing market in terms of revenue in 2024, due to the large production of therapeutic drugs and growing investment in R&D by companies for drug development.

• North America is the leading regional market and accounted for the largest revenue share in 2024 primarily due to the existence of a large number of healthcare companies including pharmaceuticals and medical devices in this region.

• The Asia Pacific region is anticipated to be the fastest-growing market during the study period. The growing prevalence rate of chronic diseases in Asian countries including India and China is a major factor contributing to the expansion of the market in this region.

Pyrogen Testing Market Segmentation

Grand View Research has segmented the global pyrogen testing market report based on product, test type, end-use, and region:

Pyrogen Testing Product Outlook (Revenue, USD Billion, 2018 - 2030)

• Consumables

• Instruments

• Services

Pyrogen Testing Test Type Outlook (Revenue, USD Billion, Number of Tests, in Thousands, 2018 - 2030)

• LAL test

  • Chromogenic test

  • Turbidimetric test

  • Gel clot test

• In vitro pyrogen test

  • Recombinant Factor C (rFC) testing

  • Monocyte Activation Test (MAT)

• Rabbit test

Pyrogen Testing End-use Outlook (Revenue, USD Billion, 2018 - 2030)

• Pharmaceutical and biotechnology companies

• Medical devices companies

• Others

Pyrogen Testing Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • U.K.

  • France

  • Italy

  • Spain

  • Sweden

  • Denmark

  • Norway

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in Pyrogen Testing Market

• Charles River Laboratories

• Novo Nordisk

• Merck KGaA

• GenScript

• bioMérieux SA

• Lonza Group

• Thermo Fisher Scientific, Inc.

• Seikagaku Biobusiness Corporation

• FUJIFILM Wako Chemicals U.S.A. Corporation (Pyrostar)

• MiCAN Technologies Inc.